The Interplay of Aging & Fibrosis: AI-Powered Target Discovery & Validation of Novel Pan-Fibrotic Protein Targets
Time: 4:20 pm
day: Day One
Details:
- Discuss senofibrosis and fibrosenescenc: The role of fibrosis in aging
- Examine the discovery of novel targets in fibrosis
- Explore generation of novel molecules for pan-fibrotic targets
- Analyze in-vivo and in-vitro validation of novel pan-fibrotics
Speakers:
Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leader in next-generation artificial intelligence technologies for drug discovery, biomarker development. He is also the founder and CEO of Deep Longevity, Inc, a global company developing a broad range of artificial intelligence-based biomarkers of aging and longevity. Since 2015 he invented critical…Read more